Your browser doesn't support javascript.
loading
IT/QA and Regulatory Aspects of Digital Pathology: Results of the 8th ESTP International Workshop.
Boisclair, Julie; Bawa, Bhupinder; Barale-Thomas, Erio; Bertrand, Lise; Carter, Jonathan; Crossland, Richard; Dorn, Celine; Forest, Thomas; Grote, Sabine; Gilis, Anja; Hildebrand, Deon; Knight, Brian; Laurent, Sébastien; Marxfeld, Heike Antje; Østergaard, Steen Jørgen; Roguet, Thibault; Schlueter, Thorsten; Schumacher, Vanessa; Spehar, Richard; Varady, William; Zeugin, Christian.
Afiliação
  • Boisclair J; Novartis Pharma, Basel, Switzerland.
  • Bawa B; AbbVie, North Chicago, Illinois, USA.
  • Barale-Thomas E; Janssen Pharmaceuticals, Beerse, Belgium.
  • Bertrand L; Charles River Laboratories, Lyon, France.
  • Carter J; Labcorp Early Development Laboratories, Harrogate, UK.
  • Crossland R; Labcorp Early Development Laboratories, Harrogate, UK.
  • Dorn C; Novartis Pharma, Basel, Switzerland.
  • Forest T; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Grote S; AbbVie, Ludwigshafen, Germany.
  • Gilis A; Janssen Pharmaceuticals, Beerse, Belgium.
  • Hildebrand D; GlaxoSmithKline, Stevenage, UK.
  • Knight B; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.
  • Laurent S; Sanofi, Montpellier, France.
  • Marxfeld HA; BASF SE, Ludwigshafen, Germany.
  • Østergaard SJ; Novo Nordisk, Maaloev, Denmark.
  • Roguet T; ANSM, Ile-de-France, France.
  • Schlueter T; Bayer, Berlin, Germany.
  • Schumacher V; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Spehar R; Janssen Pharmaceuticals, Beerse, Belgium.
  • Varady W; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.
  • Zeugin C; Novartis Pharma, Basel, Switzerland.
Toxicol Pathol ; 50(6): 793-807, 2022 08.
Article em En | MEDLINE | ID: mdl-35950710
ABSTRACT
Digital toxicologic histopathology has been broadly adopted in preclinical compound development for informal consultation and peer review. There is now increased interest in implementing the technology for good laboratory practice-regulated study evaluations. However, the implementation is not straightforward because systems and work processes require qualification and validation, with consideration also given to security. As a result of the high-throughput, high-volume nature of safety evaluations, computer performance, ergonomics, efficiency, and integration with laboratory information management systems are further key considerations. The European Society of Toxicologic Pathology organized an international expert workshop with participation by toxicologic pathologists, quality assurance/regulatory experts, and information technology experts to discuss qualification and validation of digital histopathology systems in a good laboratory practice environment, and to share the resulting conclusions broadly in the toxicologic pathology community.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Patologia / Revisão por Pares Limite: Humans Idioma: En Revista: Toxicol Pathol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Patologia / Revisão por Pares Limite: Humans Idioma: En Revista: Toxicol Pathol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça